An Interview with Dr. Adam Friedman
Download Your Copy
We respect your privacy, by submitting this form you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest. For further information on how we process and monitor your personal data click here.
An interivew with Dr. Adam Friedman, Chief Resident at the Department of Dermatology at Albert Einstein College of Medicine, on sustained release of Nitric Oxcide from the Hybrid Nanoparticle Platform: A novel therapeutic strategy for cutaneus infections.
To continue reading this story get free access
Please note: That all fields marked with an asterisk (*) are required.